Heidelberg Pharma AG
XMUN:HPHA
Heidelberg Pharma AG
XMUN:HPHA
Kurs:
2,73
EUR
Markt geschlossen
Marktkap.:
€127,23 Mio.
Notiz hinzufügen
Kursziel hinzufügen
Gedanken festhalten und ein Kursziel setzen
Legen Sie fest, zu welchem Kurs Sie kaufen würden. Wir helfen Ihnen, bereit zu bleiben.
Basierend auf
Sicherheitsmarge
0%
10%
20%
30%
40%
50%
Ihr Kursziel
Verknüpft mit
aktuellem Kurs
· In Kaufzone
Lädt
Notiz verknüpft
Wählen Sie die Aktie, die Sie mit einem Kursziel beobachten möchten
Zuletzt angesehen
|
H
|
Heidelberg Pharma AG
XMUN:HPHA
|
DE |
|
Suburban Propane Partners LP
NYSE:SPH
|
US |
|
RH
F:RS1
|
US |
|
Zhejiang China Commodities City Group Co Ltd
SSE:600415
|
CN |
Cashflow-Rechnung
Cashflow-Rechnung
Heidelberg Pharma AG
Heidelberg Pharma AG
Währung: EUR
| Feb-2020 | May-2020 | Aug-2020 | Nov-2020 | Feb-2021 | May-2021 | Aug-2021 | Nov-2021 | Feb-2022 | May-2022 | Aug-2022 | Nov-2022 | Feb-2023 | May-2023 | Aug-2023 | Nov-2023 | Feb-2024 | May-2024 | Aug-2024 | Nov-2024 | Feb-2025 | May-2025 | Aug-2025 | Nov-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operativer Cashflow | |||||||||||||||||||||||||
| Nettogewinn |
(15)
|
(15)
|
(17)
|
(18)
|
(20)
|
(22)
|
(25)
|
(26)
|
(27)
|
(22)
|
(21)
|
(20)
|
(19)
|
(27)
|
(22)
|
(20)
|
(18)
|
(13)
|
(19)
|
(19)
|
(21)
|
(23)
|
(26)
|
(42)
|
|
| Abschreibungen |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
|
| Aktienbasierte Vergütung |
1
|
1
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Sonstige nicht zahlungswirksame Posten |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
(6)
|
(4)
|
(4)
|
(5)
|
2
|
0
|
1
|
(2)
|
(3)
|
7
|
|
| Gezahlte Zinsen |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Veränderung des Working Capital |
(0)
|
3
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
13
|
11
|
10
|
5
|
(8)
|
(7)
|
(10)
|
(12)
|
(16)
|
(14)
|
(11)
|
(8)
|
(2)
|
(3)
|
1
|
|
| Cashflow aus operativer Tätigkeit |
(13)
N/A
|
(11)
+16%
|
(17)
-49%
|
(18)
-8%
|
(20)
-11%
|
(23)
-14%
|
(23)
-3%
|
(27)
-14%
|
(27)
+0%
|
(6)
+76%
|
(8)
-31%
|
(9)
-5%
|
(13)
-48%
|
(34)
-161%
|
(34)
0%
|
(34)
+1%
|
(34)
0%
|
(32)
+4%
|
(30)
+8%
|
(30)
+1%
|
(27)
+7%
|
(27)
+2%
|
(32)
-18%
|
(32)
+0%
|
|
| Investitions-Cashflow | |||||||||||||||||||||||||
| Investitionsausgaben |
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Sonstige Posten |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
7
|
7
|
7
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Cashflow aus Investitionstätigkeit |
(1)
N/A
|
(1)
+14%
|
(1)
-2%
|
(1)
-12%
|
(1)
-8%
|
(1)
-3%
|
(1)
-4%
|
(1)
+6%
|
(1)
+25%
|
(1)
+37%
|
(1)
+24%
|
(1)
-18%
|
(1)
-36%
|
(1)
-53%
|
6
N/A
|
6
+5%
|
6
+4%
|
7
+7%
|
(0)
N/A
|
(0)
-56%
|
(1)
-18%
|
(0)
+16%
|
(0)
+19%
|
(0)
+63%
|
|
| Finanzierungs-Cashflow | |||||||||||||||||||||||||
| Nettoausgabe von Stammaktien |
0
|
14
|
14
|
14
|
0
|
0
|
20
|
20
|
0
|
20
|
0
|
80
|
0
|
80
|
80
|
0
|
0
|
0
|
0
|
23
|
0
|
0
|
23
|
19
|
|
| Nettoaufnahme von Schulden |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
10
|
10
|
10
|
15
|
5
|
5
|
5
|
(5)
|
(5)
|
(10)
|
(10)
|
(5)
|
(10)
|
(5)
|
(5)
|
(5)
|
(0)
|
(0)
|
(0)
|
|
| Sonstiges |
0
|
(0)
|
(0)
|
(0)
|
5
|
(0)
|
(1)
|
(1)
|
0
|
0
|
0
|
(1)
|
0
|
(1)
|
(1)
|
0
|
0
|
21
|
21
|
(2)
|
0
|
(5)
|
(5)
|
(0)
|
|
| Cashflow aus Finanzierungstätigkeit |
(0)
N/A
|
14
N/A
|
14
0%
|
14
+0%
|
19
+35%
|
10
-48%
|
29
+193%
|
29
0%
|
29
+0%
|
24
-17%
|
5
-80%
|
84
+1.610%
|
74
-12%
|
74
+0%
|
69
-7%
|
(10)
N/A
|
(5)
+50%
|
11
N/A
|
16
+45%
|
16
+0%
|
16
0%
|
18
+12%
|
18
+2%
|
18
0%
|
|
| Veränderung der Zahlungsmittel | |||||||||||||||||||||||||
| Effekt von Wechselkursänderungen |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
|
| Nettoveränderung der Zahlungsmittel |
(15)
N/A
|
2
N/A
|
(3)
N/A
|
(5)
-41%
|
(2)
+59%
|
(14)
-614%
|
4
N/A
|
1
-73%
|
2
+38%
|
17
+968%
|
(3)
N/A
|
75
N/A
|
60
-20%
|
39
-35%
|
40
+2%
|
(38)
N/A
|
(32)
+15%
|
(15)
+54%
|
(14)
+4%
|
(14)
+1%
|
(12)
+15%
|
(9)
+22%
|
(14)
-46%
|
(14)
-5%
|
|
| Free Cashflow | |||||||||||||||||||||||||
| Free Cashflow |
(14)
N/A
|
(12)
+16%
|
(18)
-45%
|
(19)
-9%
|
(21)
-11%
|
(24)
-14%
|
(25)
-3%
|
(28)
-12%
|
(28)
+1%
|
(7)
+74%
|
(9)
-26%
|
(9)
-6%
|
(14)
-47%
|
(35)
-154%
|
(35)
0%
|
(35)
+2%
|
(34)
+1%
|
(33)
+5%
|
(30)
+7%
|
(30)
+1%
|
(28)
+7%
|
(27)
+3%
|
(32)
-17%
|
(32)
+1%
|
|
Wechseln zu:
Wechseln zu:
Auch interessant
Other Heidelberg Pharma AG listings:
Mehr entdecken
